Citation Impact
Citing Papers
Human Papillomavirus 16 E7 Oncoprotein Attenuates DNA Damage Checkpoint Control by Increasing the Proteolytic Turnover of Claspin
2009
Diversity of the Human Intestinal Microbial Flora
2005 StandoutScience
Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism
2009 StandoutScienceNobel
Human Papillomavirus E7 Oncoprotein Overrides the Tumor Suppressor Activity of p21Cip1 in Cervical Carcinogenesis
2009
Tumor-Secreted Lactic Acid Promotes IL-23/IL-17 Proinflammatory Pathway
2008
Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
2013
Macrophage Regulation of Tumor Responses to Anticancer Therapies
2013
Hallmarks of Cancer: The Next Generation
2011 Standout
Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
2010
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-κB and NFAT
2001
Activators and target genes of Rel/NF-κB transcription factors
1999 Standout
Angiogenesis in pre-malignant conditions
2009
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Tumor Self-Seeding by Circulating Cancer Cells
2009
The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells
2013
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Enhanced Antitumor Efficacy of Vasculostatin (Vstat120) Expressing Oncolytic HSV-1
2009
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Cancer Metastasis: Building a Framework
2006 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
The role of myeloid cells in the promotion of tumour angiogenesis
2008
E6 and E7 Gene Silencing and Transformed Phenotype of Human Papillomavirus 16-Positive Oropharyngeal Cancer Cells
2009
Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3
2000
Inflammation and colorectal cancer
2009
Oncogenic activities of human papillomaviruses
2009
Genetic determinants of cancer metastasis
2007
Control of apoptosis by Rel/NF-κB transcription factors
1999
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal Tumors
2007
The human papillomavirus E7 oncoprotein
2008
Leukocytes in Mammary Development and Cancer
2010
Müllerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFκB-mediated Pathway
2000
CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages
2009
Immune-mediated mechanisms influencing the efficacy of anticancer therapies
2015
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Cancer as an overhealing wound: an old hypothesis revisited
2008 Standout
Human papillomavirus and cervical cancer
2007 Standout
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Expression of the NF-κB target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells
2001
Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling
2006
Osteoclast differentiation and activation
2003 StandoutNature
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
2010
Origin and physiological roles of inflammation
2008 StandoutNature
Microenvironmental regulation of metastasis
2008 Standout
The role of human papillomavirus oncoproteins E6 and E7 in apoptosis
2002
STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice
2008
The Hallmarks of Aging
2013 Standout
Centriole overduplication through the concurrent formation of multiple daughter centrioles at single maternal templates
2007
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development
2001
Cancer-related inflammation
2008 StandoutNature
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Stromal Fibroblasts in Cancer: A Novel Tumor-Promoting Cell Type
2006
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Polarized immune responses differentially regulate cancer development
2008
Mechanisms of genomic instability in human cancer: Insights from studies with human papillomavirus oncoproteins
2003
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
1999 StandoutNature
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
The E3 Ubiquitin Ligase Mind Bomb 1 Controls Adenovirus Genome Release at the Nuclear Pore Complex
2019
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
Inflammation, inflammatory cells and angiogenesis: decisions and indecisions
2007
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
2010
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Cancer related inflammation: The macrophage connection
2008
Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice
2002 StandoutNobel
Dual modulation of cell survival and cell death by β 2 -adrenergic signaling in adult mouse cardiac myocytes
2001 StandoutNobel
Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600
2005
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Aberrant NF-κB signaling in lymphoma: mechanisms, consequences, and therapeutic implications
2006
β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα
2004 StandoutNobel
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Akt Suppresses Apoptosis by Stimulating the Transactivation Potential of the RelA/p65 Subunit of NF-κB
2000
Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes
2001
The nuclear factor kappa B (NF-κB): A potential therapeutic target for estrogen receptor negative breast cancers
2001
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
Mixed-Lineage Kinase 3 Delivers CD3/CD28-Derived Signals into the IκB Kinase Complex
2000
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Premetastatic Lung “Niche”: Is Vascular Endothelial Growth Factor Receptor 1 Activation Required?
2010
Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation
2016
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins
2011 StandoutNobel
Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis.
2003
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Human Papillomavirus E6 Proteins Mediate Resistance to Interferon-Induced Growth Arrest through Inhibition of p53 Acetylation
2007
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
1999
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
Human Papillomavirus Type 16 E7 Oncoprotein Associates with E2F6
2008
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Increased Susceptibility to Colitis-Associated Cancer of Mice Lacking TIR8, an Inhibitory Member of the Interleukin-1 Receptor Family
2007
Direct Activation of Cyclin-Dependent Kinase 2 by Human Papillomavirus E7
2003
Interferons, immunity and cancer immunoediting
2006
Top-down design of protein architectures with reinforcement learning
2023 StandoutScienceNobel
E3 ubiquitin ligase Mindbomb 1 facilitates nuclear delivery of adenovirus genomes
2020 StandoutNobel
Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe
2009
The Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition
2001
Works of Alexandra Eichten being referenced
Angiopoietin-2 Functions as a Tie2 Agonist in Tumor Models, Where It Limits the Effects of VEGF Inhibition
2012
Molecular pathways executing the “trophic sentinel” response in HPV-16 E7-expressing normal human diploid fibroblasts upon growth factor deprivation
2003
Analysis of Immune Cell Infiltrates during Squamous Carcinoma Development
2006
Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development
2007
Paradoxical roles of the immune system during cancer development
2006 Standout
Biological activities and molecular targets of the human papillomavirus E7 oncoprotein
2001
Stabilization and Functional Impairment of the Tumor Suppressor p53 by the Human Papillomavirus Type 16 E7 Oncoprotein
2002
Distinctive Features of Angiogenesis and Lymphangiogenesis Determine Their Functionality during De novo Tumor Development
2007
NF-kappaB-mediated induction of p21(Cip1/Waf1) by tumor necrosis factor alpha induces growth arrest and cytoprotection in normal human keratinocytes.
2003
NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition
1999